- Research works
- 47 ▲ 53% vs 2013–17
- Citations
- 401 8.6 per fractional work
- Top-10% rate
- 3.2% record average 16.5%
- Open access
- 57% world 28%
Not ranked overall: Bühlmann (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 25.2×. Every wedge is a field page.
Which keywords describe research at Bühlmann (Switzerland)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Epidemiology, Innate Immunity, Calcium Modulated Proteins, S100 Proteins, Acute Pancreatitis, Adverse Drug Reactions and Chronic Pancreatitis.
- Tuberculosis
- Mycobacterium tuberculosis
- Innate Memory
- Monoclonal Antibodies
- Cancer
- Clinical Pharmacy
- Chronic Pancreatitis
- Acute Pancreatitis
- Calcium Modulated Proteins
- Epidemiology
- Inflammation
- Innate Immunity
- S100 Proteins
- Adverse Drug Reactions
- Glycosylation
- Pharmaceutical Care
- Diagnosis
- Immune Response
- Medication Adherence
- Trained Immunity
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 20 words, with their numbers
- Inflammation4▲ 8.8×7 topics
- Epidemiology4▲ 4.5×3 topics
- Innate Immunity3▲ 43×3 topics
- Calcium Modulated Proteins3▲ 658×1 topic
- S100 Proteins3▲ 658×1 topic
- Acute Pancreatitis2▲ 285×1 topic
- Adverse Drug Reactions2▲ 227×3 topics
- Chronic Pancreatitis2▲ 285×1 topic
- Glycosylation2▲ 72×2 topics
- Clinical Pharmacy2▲ 654×1 topic
- Pharmaceutical Care2▲ 654×1 topic
- Cancer1▲ 4.2×4 topics
- Diagnosis1▲ 6.1×2 topics
- Monoclonal Antibodies1▲ 68×2 topics
- Immune Response1▲ 8.8×2 topics
- Innate Memory1▲ 218×1 topic
- Medication Adherence1▲ 90×2 topics
- Mycobacterium tuberculosis1▲ 88×1 topic
- Trained Immunity1▲ 218×1 topic
- Tuberculosis1▲ 93×1 topic
Which research topics does Bühlmann (Switzerland) publish most on?
By volume in 2022–2025: S100 Proteins and Annexins, Pancreatitis Pathology and Treatment, Pharmacy and Medical Practices and Immune responses and vaccinations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 S100 Proteins and Annexins Molecular Biology 3 works
- 2 Pancreatitis Pathology and Treatment Surgery 2 works
- 3 Pharmacy and Medical Practices Pharmacology 2 works
- 4 Immune responses and vaccinations Immunology 1 works
- 5 Tuberculosis Research and Epidemiology Infectious Diseases 1 works
- 6 Glycosylation and Glycoproteins Research Molecular Biology 1 works
- 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 8 Mast cells and histamine Immunology 1 works
- 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
- 10 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bühlmann (Switzerland)'s research output changed?
Output in 2018–2022 was 53% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.